Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)

Concomitant radiochemotherapy (RTCT) is the standard treatment for unresectable stage III non-small cell lung cancer (NSCLC). However, in patients with a peripheral primary tumor, the irradiated volume may include a large portion of normal lung and RT-CT is not possible. This multicenter phase II tr...

Cijeli opis

Bibliografski detalji

Glavni autori:	Isabelle Martel-Lafay, Isabelle Monnet, Audrey Lardy-Cleaud, Serge Danhier, Naji Salem, Olivier Gallocher, Pierre Fournel, Christos Chouaid, Olivier Bylicki, the GFPC 01-14 Investigators
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2021-09-01
Serija:	Current Oncology
Teme:	stereotactic body radiation therapy concomitant radiochemotherapy unresectable stage III NSCLC
Online pristup:	https://www.mdpi.com/1718-7729/28/5/324
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!